US 8895740
Pyrazolopyrazine kinase inhibitors
granted A61PA61P1/00A61P11/06
Quick answer
US patent 8895740 (Pyrazolopyrazine kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61P, A61P1/00, A61P11/06, A61P17/06, A61P19/02